文献速递乳腺病理

免疫组化在乳腺肿瘤诊断与分类中的应用

Immunohistochemistry in the Diagnosis and Classification of Breast Tumors.
PubMed 文献 · Arch Pathol Lab Med · 2023-01-01

该综述基于文献回顾与作者作为乳腺病理医生的临床经验,概述了目前用于诊断乳腺病变的免疫组化标志物。文章总结了免疫组化在诊断不同类型乳腺病变(尤其浸润性与非浸润性病变、良恶性梭形细胞病变)中的常见用途,并介绍了诊断性癌标志物的前沿知识,强调了解这些标志物的优势与局限对乳腺病理临床实践至关重要。

要点

  • 免疫组化广泛用于乳腺病变的诊断与分类。
  • 综述涵盖浸润性与非浸润性、良恶性梭形细胞病变的标志物使用。
  • 掌握标志物的优势与局限是乳腺病理临床实践的关键。

核心结论

  • 免疫组化在乳腺病变诊断与分类中广泛使用,了解标志物的优势与局限对临床实践至关重要。

研究设计与样本

  • 综述,数据来源于文献回顾与作者作为乳腺病理医生的临床经验。

主要发现

  • 总结了免疫组化在诊断不同类型乳腺病变中的常见用途,尤其浸润性与非浸润性病变、良恶性梭形细胞病变。
  • 介绍了诊断性癌标志物的前沿知识,有助于理解不同乳腺癌类型并将乳腺癌与形态相似的其他癌区分。

临床怎么用

  • 在乳腺病理诊断与分类中应用免疫组化标志物时,需了解其优势与局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: In the clinical practice of breast pathology, immunohistochemistry (IHC) of different markers is widely used for the diagnosis and classification of breast lesions. OBJECTIVE.—: To provide an overview of currently used and recently identified IHC stains that have been implemented in the field of diagnostic breast pathology. DATA SOURCES.—: Data were obtained from literature review and clinical experience of the authors as breast pathologists. CONCLUSIONS.—: In the current review, we summarize the common uses of IHC stains for diagnosing different types of breast lesions, especially invasive and noninvasive breast lesions, and benign and malignant spindle cell lesions. In addition, the cutting-edge knowledge of diagnostic carcinoma markers will lead us to further understand the different types of breast carcinoma and differentiate breast carcinomas from other carcinomas of similar morphology. Knowing the strengths and limitations of these markers is essential to the clinical practice of breast pathology.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Sun H, Ding Q, Sahin AA, et al. Immunohistochemistry in the Diagnosis and Classification of Breast Tumors. Arch Pathol Lab Med. 2023. PMID: 37490413. doi:10.5858/arpa.2022-0464-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。